LINC00930

Across TCGA pan-cancer cohorts, LINC00930 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated LINC00930 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LINC00930 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00930 expression acts as an unfavorable survival marker, although some lineages such as BLCA and PAAD show a favorable association.

UVM, BLCA, and KIRC are the cancer types where LINC00930 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Quartile	All	0.305	0.879	<.001	82	view →
BLCA	OS	Median	All	0.672	0.547	<.001	80	view →
KIRC	DFS	Tertile	All	0.494	0.714	<.001	67	view →
PAAD	DFS	Tertile	All	0.550	0.364	.005	49	view →
UCEC	DFS	Median	All	0.898	0.778	<.001	42	view →
LIHC	DFS	Median	III,IV	0.477	0.257	.001	36	view →
LGG	DFS	Tertile	All	0.338	0.523	<.001	22	view →
PRAD	DFS	Quartile	All	0.756	0.901	.010	20	view →
HNSC	DFS	Median	IV	0.482	0.262	.014	16	view →
ESCA	DFS	Median	II,III,IV	0.374	1.000	.006	12	view →
THCA	DFS	Tertile	All	0.891	0.796	.013	10	view →
SKCM	DFS	Tertile	IV	0.057	0.610	.017	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

LINC00930–UVM (DFS)

Open the UVM breakdown →